- Open Clinical Trials
- Closed Clinical Trials
- Research Achievements
- Research Development and Funding
- BCT Trials & Projects Summary
- Clinical Fellowship Program
- What is a Clinical Trial?
- Why Participate in a Clinical Trial?
- Research Blog
- Participating Institutions
- International Collaboration
- Annual Scientific Meeting
- Travel Grants and Awards
- Our Impact
- Researcher Login
Who is Involved in Breast Cancer Trials Research?
For more than 40 years, Breast Cancer Trials (BCT) has provided an essential coordinated structure for the conduct of collaborative breast cancer clinical trials research in Australia and New Zealand.
Clinical trials are the essential tool to identify the safety and benefit of new treatments and treatment strategies before they can be made widely available to all breast cancer patients. All of the current treatments for breast cancer have proceeded through the rigorous clinical trials process.
Because small differences in outcomes may be very important if they are genuine, it is essential that a new treatment is tested in a very large number of women so that small gains do not go undetected. It is simply not possible for a single doctor or even a single institution to have enough experiences on their own to answer such questions.
This is why BCT was formed – to pool experiences and resources to obtain reliable answers more quickly for the benefit of all patients affected by breast cancer.
There are currently 835 BCT members, representing 109 institutions throughout Australia and New Zealand. Our membership includes all professions involved in breast cancer.
There are currently 835 BCT members, representing 109 institutions throughout Australia and New Zealand. Our membership includes all professions involved in breast cancer treatment, detection and care, including medical oncologists, surgeons, radiation oncologists, pathologists, endocrinologists, haematologists, pharmacists, geneticists, psychologists, counsellors, data managers, research nurses, consumers, and other clinical trials management. BCT is also a sustaining member of the Clinical Oncological Society of Australia (COSA).